Paediatric hepatitis C virus infection and its treatment: Present, past, and future

被引：2
|
作者：
El-Shabrawi, Mortada [1 ]
Hassanin, Fetouh [2 ]
机构：
[1] Cairo Univ, Fac Med, Paediat Dept, Cairo, Egypt
[2] Misr Int Univ, Cairo, Egypt
来源：
ARAB JOURNAL OF GASTROENTEROLOGY | 2019年 / 20卷 / 03期
关键词：
HCV; Children; Treatment; DAAs; DIRECT-ACTING ANTIVIRALS; TRANSFUSION-ASSOCIATED HEPATITIS; SUSTAINED VIROLOGICAL RESPONSE; TERM HISTOLOGIC IMPROVEMENT; DACLATASVIR PLUS SOFOSBUVIR; QUALITY-OF-LIFE; CHRONIC NON-A; INTERFERON-ALPHA; VIRAL-HEPATITIS; RIBAVIRIN TREATMENT;
D O I：
10.1016/j.ajg.2019.09.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease in the world. It is a challenging medico-social problem in the paediatric population. High HCV infection rates are reported in low and middle incomes countries. From the health economic point of view treatment of hepatitis C virus (HCV) with subsequent virus eradication is very effective as it eliminates the long-term sequelae of untreated or maltreated HCV In this review we summarize the updates and highlight the historical approach of treatment of chronic HCV infection in children in the new era of directly acting antiviral (DAA) agents. (C) 2019 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：163 / 174
页数：12
相关论文
共 50 条
  • [31] Host-targeting therapies for hepatitis C virus infection: current developments and future applications
    Crouchet, Emilie
    Wrensch, Florian
    Schuster, Catherine
    Zeisel, Mirjam B.
    Baumert, Thomas F.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2018, 11
  • [32] Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: Past, present and future
    Jérme Dumortier
    Olivier Boillot
    Jean-Yves Scoazec
    World Journal of Gastroenterology, 2014, (32) : 11069 - 11079
  • [33] Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
    Chandana Papudesu
    Shyamasundaran Kottilil
    Shashwatee Bagchi
    Hepatology International, 2017, 11 : 152 - 160
  • [34] Treatment of early stage chronic hepatitis C virus infection
    Ponziani, Francesca Romana
    Miele, Luca
    Tortora, Annalisa
    Furnari, Manuele
    Bodini, Giorgia
    Pompili, Maurizio
    Gasbarrini, Antonio
    Giannini, Edoardo Giovanni
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (05) : 519 - 524
  • [35] SASLT Guidelines: Update in Treatment of Hepatitis C Virus Infection
    Alghamdi, Abdullah S.
    Alghamdi, Mohammed
    Sanai, Faisal M.
    Alghamdi, Hamdan
    Aba-Alkhail, Faisal
    Alswat, Khalid
    Babatin, Mohammed
    Alqutub, Adel
    Altraif, Ibrahim
    Alfaleh, Faleh
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2016, 22 (08): : S25 - S57
  • [36] Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
    Papudesu, Chandana
    Kottilil, Shyamasundaran
    Bagchi, Shashwatee
    HEPATOLOGY INTERNATIONAL, 2017, 11 (02) : 152 - 160
  • [37] Hepatitis C Virus: Insights Into Its History, Treatment, Challenges, and Future Directions
    Bernal, Luis A.
    Soti, Varun
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [38] Treatment of acute hepatitis C virus infection
    Vogel, W
    JOURNAL OF HEPATOLOGY, 1999, 31 : 189 - 192
  • [39] Individualized treatment of hepatitis C virus infection
    Pol, Stanislas
    Fontaine, Helene
    PRESSE MEDICALE, 2012, 41 (02): : 146 - 152
  • [40] Paediatric palliative medicine in the UK: past, present, future
    Hain, Richard
    Heckford, Emma
    McCulloch, Renee
    ARCHIVES OF DISEASE IN CHILDHOOD, 2012, 97 (04) : 381 - 384
12345